Navigating Canadian Benefits Costs: 2026-2027 Insights

Why Canadian employers should prepare for continued cost pressure—and look beyond the headline renewal increase

Executive Summary

Canadian employers entering the 2026–2027 benefits cycle should expect one theme to dominate renewal discussions:

continued upward pressure on benefits costs.

The forces behind that pressure are broader than general inflation.

Prescription-drug costs continue to evolve as expensive specialty therapies become more prevalent. Mental-health utilization remains important. Disability experience can materially affect insured rates. Dental and paramedical utilization can shift quickly. An aging workforce can change the claims profile. New treatments are improving health outcomes while sometimes increasing the cost of care.

International research reinforces the direction of travel. Mercer Marsh Benefits’ 2026 Health Trends research found projected medical trend remained in double digits across most markets, with medical inflation and increased utilization among the leading drivers. Aon’s 2027 global research projects average medical trend of 9.0% globally, even as the rate of increase begins to ease.

Those figures should not be interpreted as Canadian group-benefits renewal forecasts.

Canada’s employer benefits system differs materially from markets where employers finance much more of the core healthcare system.

But the underlying message is relevant:

Healthcare costs are likely to continue increasing faster than many employers’ broader budgets.

For Canadian plan sponsors, 2026–2027 should therefore be less about predicting a single renewal percentage and more about understanding the individual forces driving their own plan.

The employers best positioned for the next two years will be those that can distinguish between market trend, their own claims experience, insurer pricing, catastrophic risk and avoidable plan inefficiency.

The 2026–2027 Outlook: Continued Pressure, but Not One Number

Employers frequently ask:

What should we budget for our benefits renewal next year?

There is no responsible universal answer.

A Canadian employer’s renewal can be influenced by:

Prescription-drug claims
Specialty medications
Dental utilization
Paramedical utilization
Mental-health claims
Disability experience
Workforce demographics
Employee growth or contraction
Plan-design changes
Inflation
Pooling costs
Insurer expenses
Funding arrangements
Prior-year rate adequacy
Credibility of the employer’s own experience

Two employers of similar size can therefore receive materially different renewal results.

The more useful question is:

Which cost pressures are likely to affect our plan, and how exposed are we to each of them?

Medical Trend Is Not the Same as Your Renewal

This distinction is critical.

Medical or benefits trend attempts to describe the expected underlying change in healthcare costs.

A renewal is the pricing adjustment required for a specific benefits plan.

At a simplified level:

Expected future claims = current claims × expected trend, adjusted for plan and workforce changes

The insurer may then incorporate other factors such as:

Credibility
Pooling
Expenses
Reserves
Risk charges
Taxes
Prior-period performance

An employer can therefore experience a relatively moderate market trend and still receive a significant renewal increase.

Conversely, an organization with favourable experience could receive a lower adjustment despite broader market pressure.

Trend describes the environment. Renewal describes your plan.

Employers should not confuse the two.

The Forces Shaping 2026–2027 Pricing

Cost Driver	Expected Direction	Why It Matters
Prescription Drugs	Upward	Specialty therapies and evolving treatment options can materially affect claims
Specialty Drugs	Strong upward pressure	Small numbers of claimants can create significant plan costs
Mental Health	Continued pressure	Greater utilization and demand for meaningful treatment
Dental	Upward	Provider fees and utilization can affect experience
Paramedical	Moderate to upward	Utilization remains significant in many plans
Disability	Employer-specific	Incidence, duration and salary levels can materially affect pricing
Pooling / Stop-Loss	Upward pressure	Increasing severity of catastrophic claims affects risk-transfer costs
Workforce Aging	Gradual upward pressure	Health and disability utilization can change with demographics
New Treatments	Upward, with potential offsets	More effective therapies may cost more but improve longer-term outcomes
Virtual & Digital Health	Mixed	Additional fees may be offset by better access or earlier intervention
Plan Design	Employer-controlled	Richer coverage increases exposure; targeted management can improve sustainability

The significance of each driver will vary by employer.

Prescription Drugs Remain One of the Most Important Cost Drivers

Drug plans deserve particular attention entering 2026–2027.

The issue is not simply that existing medications become more expensive.

The treatment mix is changing.

New therapies can provide meaningful clinical benefits for employees living with serious or chronic conditions.

But some come with significant costs.

Employers should monitor:

Drug spend per employee
Number of claimants
High-cost claimants
Specialty-drug utilization
Therapeutic categories
Prior-authorization outcomes
Biosimilar utilization
Recurring high-cost claims
Public-plan coordination

A relatively small number of claims can increasingly influence total drug-plan economics.

That makes drug governance one of the most important capabilities for benefits sponsors.

Specialty Drugs Continue to Change the Risk Profile

Traditional benefits plans were built largely around predictable volumes of relatively modest health claims.

Specialty medications create a different financial dynamic.

A single claimant can potentially generate very significant annual costs.

Several such claimants can materially alter an employer’s experience.

This is why employers need to understand:

Pooling thresholds
Stop-loss arrangements
Recurring-claim treatment
Specialty-pharmacy programs
Patient-support programs
Prior authorization
Public funding
Biosimilar strategies

The objective is not simply to restrict access.

It is to ensure appropriate treatment while managing how exceptionally expensive claims are financed.

GLP-1s Add Another Dimension to Drug-Plan Strategy

The growth of GLP-1 medications has added a new dimension to employer drug-plan discussions.

Originally associated primarily with diabetes treatment, these therapies have increasingly become part of the broader conversation around obesity and metabolic health.

For employers, this raises several questions:

What indications should be covered?
What clinical criteria should apply?
Should prior authorization be required?
How should obesity be treated within the organization’s health strategy?
What are the potential long-term health benefits?
What is the near-term financial exposure?

International employer research has already identified increased prescription-drug spending, including growing utilization of GLP-1 medications, as a meaningful healthcare cost pressure.

The strategic mistake would be viewing the issue purely through either a cost or access lens.

Employers need both.

Mental-Health Spending Is Becoming Structural

Mental-health benefits expanded considerably across many employer plans over the past several years.

Employee demand remains significant.

That means mental-health spending should increasingly be viewed as a structural component of the benefits program rather than a temporary utilization spike.

Employers should examine:

Psychology claims
Psychotherapy claims
Employee Assistance Program utilization
Virtual mental-health utilization
Mental-health disability
Duration of disability claims
Access to treatment
Provider availability

The important question is not simply:

Are mental-health claims increasing?

It is:

Are employees receiving effective support early enough to improve health and prevent more serious absence or disability?

Higher outpatient mental-health spending can be entirely rational if it contributes to better employee outcomes.

Disability Could Become the Hidden Renewal Story

Health and dental often receive the most attention because employees use them frequently.

But disability can create significant financial pressure.

Long-term disability pricing can be affected by:

Claim incidence
Claim duration
Employee salaries
Workforce demographics
Occupational mix
Mental-health claims
Musculoskeletal conditions
Return-to-work outcomes
Interest-rate and insurer assumptions

For employers with deteriorating disability experience, LTD increases can materially affect the overall renewal even when health and dental experience appears manageable.

Disability therefore deserves the same governance discipline as health claims.

Higher Salaries Can Increase Insured Benefits Costs

Benefits inflation does not come only from healthcare.

Many insured benefits are salary related.

Life insurance and disability benefits may be calculated as multiples or percentages of earnings.

As salaries increase:

Higher insured earnings → higher insured exposure → potentially higher premium

This can occur even if claim incidence remains unchanged.

Employers should therefore distinguish between:

Rate increases
Payroll growth
Headcount growth
Coverage growth

Total benefits spending can rise even when insurance rates remain relatively stable.

Dental Costs Can Quietly Build Pressure

Dental rarely generates the same strategic attention as specialty drugs.

But it can represent a significant portion of employer health spending.

Cost pressure can come from:

Dental fee-guide changes
Increased utilization
Major restorative work
Orthodontics
Plan maximums
Deferred treatment returning to the system

Employers should monitor both:

Cost per claimant

and

Number of claimants

An increase in total claims can be driven by higher prices, higher utilization or both.

The management response may differ depending on the cause.

Paramedical Benefits Need More Sophisticated Analysis

Physiotherapy, massage therapy, chiropractic services and other paramedical benefits can generate substantial utilization.

High utilization is not automatically problematic.

Physiotherapy, for example, may support recovery and help prevent disability.

The relevant question is whether utilization is producing value.

Employers should examine:

Utilization by service
Average claim per user
Maximum utilization
Geographic differences
Occupational patterns
Relationship with disability
Potential fraud or abuse

Blanket reductions can save money.

They can also reduce access to services that help employees remain productive.

Public Healthcare Pressure Can Spill Into Private Plans

Canadian employer plans operate alongside provincial healthcare systems.

Pressure on public healthcare can affect private benefits indirectly.

Employees facing difficulty accessing primary care, mental-health treatment or other services may increasingly rely on employer-sponsored options where available.

Mercer Marsh Benefits identifies pressure on public health systems and increasing utilization as broader contributors to medical-plan cost pressure internationally.

For Canadian employers, this reinforces the growing importance of:

Virtual care
Mental-health services
Healthcare navigation
Second opinions
Chronic-condition support

The private plan can increasingly become part of how employees navigate an overloaded healthcare system.

Workforce Demographics Matter More Than Market Averages

Benefits pricing is partly a workforce story.

An employer with a growing population of younger employees can experience very different claims patterns from an employer with a mature, long-tenured workforce.

Important variables include:

Age
Gender mix
Family status
Occupation
Geography
Salary
Turnover
Retirement patterns

This does not mean benefits should discriminate based on demographics.

It means employers should understand how workforce composition influences claims.

A demographic shift can change benefits economics even if plan design remains exactly the same.

Inflation Still Matters—but Benefits Inflation Is Different

General inflation influences some healthcare costs.

But benefits costs do not necessarily move in line with the Consumer Price Index.

Healthcare trend can be driven by:

Provider fees
Drug prices
Treatment innovation
Utilization
New therapies
Demographics
Changes in disease prevalence

This is why employers should not automatically assume:

3% general inflation = 3% benefits trend

Healthcare economics operate differently.

Indeed, current global research continues to show medical trend running substantially above general inflation. Aon projects a 9.0% global medical trend rate for 2027 and notes that medical trend remains more than three times inflation globally.

Again, that is not a Canadian renewal forecast.

It is evidence that healthcare cost pressure remains a broader structural issue.

2027 Could Be More Challenging Than Employers Expect

There is an important warning signal in the latest international employer research.

Preliminary U.S. employer data from Marsh projects average health-benefit cost per employee to rise 8.2% in 2027 after plan changes, versus 6.7% projected for 2026. Employers estimated their existing plans would increase approximately 11% without cost-reduction measures.

The Canadian system is different, so those figures should not be imported into Canadian budgets.

But the direction matters.

Advanced treatments, utilization and persistent healthcare inflation suggest employers should not assume that cost pressure will simply return to historical norms in 2027.

Budgeting should include scenarios rather than a single optimistic assumption.

Pooling Costs Deserve More Attention

Pooling protects employers from catastrophic claims.

As the frequency and severity of high-cost claims increase, the cost of that protection can increase as well.

Employers should understand:

Current pooling threshold
Pooling charge
Claims above threshold
Recurring pooled claims
Contract provisions
Renewal methodology

For some organizations, pooling may become one of the fastest-growing components of benefits cost.

It should therefore be evaluated as a separate risk-financing decision.

Fully Insured Employers May Experience Pricing Differently

Smaller and mid-sized employers often purchase insured health and dental benefits.

Their renewal can reflect:

Own claims experience
Credibility
Insurer manual rates
Pooling
Trend assumptions
Expenses
Taxes
Risk charges

An employer’s actual experience may therefore only partially determine its renewal.

The smaller the credible population, the more market assumptions can matter.

This makes renewal analysis important.

Employers should understand not only the proposed rate but the assumptions behind it.

ASO Employers Will See Cost Pressure More Directly

Administrative Services Only arrangements expose employers more directly to claims experience.

When drug or health claims rise, the employer sees that increase through cash flow rather than waiting for it to be fully reflected in an insured renewal.

ASO employers should therefore budget for:

Expected claims
Trend
Claims volatility
Administration
Pooling
Taxes
Point solutions
Other plan expenses

Monthly reporting becomes particularly important.

The organization should know whether actual claims are tracking above or below budget well before year-end.

The Renewal Percentage Can Hide What’s Really Happening

Consider two employers that both receive an 8% renewal increase.

Employer A has:

Stable health claims
Significant LTD deterioration
Increased pooling costs

Employer B has:

Rapid drug growth
Stable disability
Increased dental utilization

The headline number is identical.

The underlying problems are completely different.

Their strategies should therefore be different.

This is why renewal management should start with:

What changed?

not:

How do we negotiate the 8% down?

Negotiating the Renewal Is Still Important

Insurer pricing should absolutely be challenged.

Employers and advisors should review:

Claims projections
Trend assumptions
Credibility
Expenses
Pooling
Reserves where applicable
Risk charges
Rate guarantees
Market competitiveness

Competitive marketing can also test whether incumbent pricing remains appropriate.

But negotiation has limits.

If employees are generating significantly more claims, moving those claims to another insurer does not make them disappear.

The long-term strategy needs to address the underlying drivers.

Cost Shifting Is the Easiest Lever—and Often the Weakest Strategy

Employers facing cost pressure can increase:

Employee contributions
Deductibles
Coinsurance
Out-of-pocket maximums
Coverage limits

These changes reduce employer cost.

They do not necessarily reduce healthcare cost.

They often simply move it to employees.

That can create unintended consequences:

Lower-paid employees may delay treatment
Employees may discontinue medication
Financial stress may increase
Benefits may become less competitive
Employee perception of the plan may deteriorate

Canadian employee research already points to affordability challenges: Mercer reported that employees with health conditions or disabilities were materially more likely to lack confidence that they could afford needed healthcare, while financial barriers contributed to delayed care.

Cost sharing should therefore be evaluated through both a financial and employee-affordability lens.

Better Cost Management Focuses on Value

The stronger alternative is benefits optimization.

That can include:

Drug-plan management
Specialty-drug governance
Biosimilar strategies
Fraud management
Disability prevention
Early intervention
Mental-health access
Healthcare navigation
Vendor consolidation
Funding optimization
Plan-design modernization

The objective is not simply to spend less.

It is to reduce low-value spending while protecting high-value coverage.

That distinction will become increasingly important if cost pressure persists through 2027.

Employers Should Budget Using Scenarios

Rather than establishing one benefits inflation assumption, employers can model several outcomes.

Scenario	Planning Assumption
Favourable	Claims remain relatively stable and renewal pressure is manageable
Expected	Normal trend plus known plan and workforce changes
Adverse	Higher drug, disability or utilization experience
Catastrophic	One or more major claims materially affect experience or pooling

The percentages assigned to these scenarios should be based on the employer’s actual plan and insurer information—not generic market numbers.

Scenario planning is particularly useful for ASO employers and organizations with volatile experience.

A Better 2026–2027 Renewal Dashboard

Employers should monitor more than the proposed renewal.

Metric	Why It Matters
Total Benefits Cost per Employee	Overall economic trend
Health Claims per Employee	Core health-plan trend
Drug Claims per Employee	Identifies pharmaceutical pressure
Specialty-Drug Claims	Measures high-cost exposure
Dental Claims per Employee	Tracks dental utilization and inflation
Mental-Health Claims	Measures utilization and access
LTD Incidence	Identifies disability risk
LTD Duration	Measures severity and return-to-work effectiveness
Pooling Cost	Tracks catastrophic risk-transfer expense
Administration Cost	Measures delivery efficiency
Employee Contributions	Tracks affordability and cost shifting
Benefits Utilization	Helps assess employee value

This creates a much more useful picture than a single renewal percentage.

Case Study: Preparing for a Difficult Benefits Renewal

Illustrative example

Context:

3,200 Canadian employees
Health and dental experience deteriorating
Significant increase in specialty-drug spending
Mental-health utilization continuing to rise
Several long-duration disability claims
Pooling costs increasing
Leadership concerned that another significant renewal would require benefit reductions
Finance wanted a more reliable 2027 forecast

Actions Taken:

Separated renewal drivers by health, dental, disability and pooling
Analyzed three years of claims per employee
Identified specialty drugs driving disproportionate growth
Reviewed prior-authorization and biosimilar strategies
Examined mental-health utilization alongside disability experience
Reviewed LTD case-management and return-to-work outcomes
Tested insurer trend and expense assumptions
Reviewed funding alternatives
Developed favourable, expected and adverse 2027 scenarios
Identified low-utilization point solutions and overlapping vendor costs
Protected core health, disability and mental-health coverage while redirecting lower-value spending

Outcomes:

Leadership gained a clearer understanding of the renewal
Finance received a more credible benefits forecast
Cost-management decisions focused on underlying claims drivers
Employee cost shifting was reduced relative to the original proposal
Drug-plan governance improved
Disability received greater management attention
Duplicate spending was identified
Renewal strategy shifted from annual negotiation toward multi-year benefits management

Strategic Takeaways for HR and Finance Leaders

Expect continued cost pressure. There is little evidence that healthcare-cost growth is disappearing in 2026–2027.
Do not use a global or U.S. trend number as your Canadian renewal assumption. Your plan experience matters more.
Separate market trend from renewal pricing. They are related but not interchangeable.
Watch prescription drugs closely. Specialty therapies can materially alter plan economics.
Develop a clear GLP-1 strategy. Coverage decisions should consider both clinical value and financial exposure.
Treat mental-health spending as structural. Focus on outcomes rather than simply utilization.
Do not overlook disability. LTD deterioration can materially affect renewal pricing.
Understand payroll effects. Salary growth can increase life and disability costs even without rate changes.
Analyze pooling separately. Catastrophic-risk protection can become a significant cost driver.
Segment claims. National averages can hide important demographic, occupational and geographic patterns.
Challenge insurer assumptions. Trend, expenses, pooling and risk charges should be understood.
Do not confuse negotiation with cost management. A lower renewal does not necessarily fix the underlying problem.
Be cautious with cost shifting. Reducing employer expense can create employee affordability problems.
Optimize value instead. Protect important coverage while removing inefficient spending.
Budget using scenarios. Benefits costs are too volatile to rely on a single-point forecast.
Build a multi-year strategy. Sustainable benefits management cannot occur once a year at renewal.

The Opportunity for Employers

2026–2027 is likely to test how Canadian employers think about benefits costs.

The easiest response to rising prices is familiar.

Negotiate harder.

Change insurers.

Increase employee contributions.

Reduce maximums.

Add deductibles.

Those actions can produce short-term savings.

But they do not necessarily create a sustainable benefits program.

The stronger approach begins with understanding the economics underneath the renewal.

Which claims are increasing?

Which conditions are driving them?

Where are employees having difficulty accessing care?

Which risks should be insured?

Which risks should be retained?

Which vendors are producing value?

Where is spending duplicated?

Which interventions could prevent larger claims later?

And which benefits are sufficiently important to employees that reducing them would create a larger talent problem than the savings justify?

That is the conversation employers should be having as they prepare for 2027.

Benefits costs will almost certainly continue to move.

The organizations that perform best will not necessarily be those that achieve the lowest renewal in a single year.

They will be those that build the data, governance and discipline to understand what is driving their costs—and act before those costs become renewal surprises.

For Canadian employers, 2026–2027 should mark a shift from managing the annual benefits renewal to managing the underlying health, risk and economics of the benefits program itself.